Cyclacel Pharmaceuticals, Inc. (CYCC):企業概要、財務及び戦略的SWOT分析

【英語タイトル】Cyclacel Pharmaceuticals, Inc. (CYCC) - Financial and Strategic SWOT Analysis Review

・産業分野:Pharmaceuticals and Healthcare
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム


Cyclacel Pharmaceuticals, Inc. (Cyclacel Pharmaceuticals) is a pharmaceutical company. The company develops oral therapies for the treatment of cancer and other serious diseases. Its products include sapacitabine, seliciclib, and CYC116. Cyclacel Pharmaceuticals’ sapacitabine is the drug candidate used to treat the patients with acute myeloid leukemia; Seliciclib is an orally available, cyclin dependent kinase inhibitor; and CYC116 is an orally-active inhibitor of Aurora kinases A and B, and VEGFR2. It offers products for anti-infective, autoimmune, cardiovascular, ophthalmic and other non-oncology indications. The company has agreement with the U.S. Food and Drug Administration. Cyclacel Pharmaceuticals is headquartered in Berkeley Heights, New Jersey, the US.

Cyclacel Pharmaceuticals, Inc. Key Recent Developments

Sep 11, 2014: Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors
Aug 12, 2014: Cyclacel Pharmaceuticals Reports Second Quarter 2014 Financial Results
May 13, 2014: Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results
Mar 25, 2014: Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
Jan 06, 2014: Cyclacel Pharmaceuticals to Present at Biotech Showcase

This comprehensive SWOT profile of Cyclacel Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cyclacel Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Cyclacel Pharmaceuticals, Inc. – Key Information
Cyclacel Pharmaceuticals, Inc. – Overview
Cyclacel Pharmaceuticals, Inc. – Key Employees
Cyclacel Pharmaceuticals, Inc. – Key Employee Biographies
Cyclacel Pharmaceuticals, Inc. – Key Operational Heads
Cyclacel Pharmaceuticals, Inc. – Major Products and Services
Cyclacel Pharmaceuticals, Inc. – History
Cyclacel Pharmaceuticals, Inc. – Company Statement
Cyclacel Pharmaceuticals, Inc. – Locations And Subsidiaries
Cyclacel Pharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cyclacel Pharmaceuticals, Inc. – Business Description
Cyclacel Pharmaceuticals, Inc. – Corporate Strategy
Cyclacel Pharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
Cyclacel Pharmaceuticals, Inc. – Strengths
Cyclacel Pharmaceuticals, Inc. – Weaknesses
Cyclacel Pharmaceuticals, Inc. – Opportunities
Cyclacel Pharmaceuticals, Inc. – Threats
Cyclacel Pharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Cyclacel Pharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

★調査レポート[Cyclacel Pharmaceuticals, Inc. (CYCC):企業概要、財務及び戦略的SWOT分析] (コード:GDPH37480FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cyclacel Pharmaceuticals, Inc. (CYCC):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせ